CTSOCytosorbents Corpvs its industry peers
A metric-by-metric comparison of Cytosorbents Corp against SIC 3841 — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| 기업 | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CTSO본 종목 | $373M#7 | — | — | 10.1x#13 | 4.1%#10 | 60.4%#3 | -39.8%#8 | — | -122.1%#11 | 4#7 | — | — |
| CERS | $504M#1 | — | 7.2x#9 | 2.2x#5 | 16.1%#7 | 25.3%#6 | -3.7%#3 | -22.3%#5 | -15.5%#5 | — | 98.4%#2 | — |
| NPCE | $488M#2 | — | 41.1x#13 | 4.9x#8 | 25.1%#5 | 20.9%#8 | -16.3%#6 | -180.6%#11 | -28.0%#7 | 4#7 | 45.1%#3 | — |
| PMI | $15M#16 | — | 8.7x#11 | 3.0x#7 | 12.5%#8 | -28.2%#12 | -268.4%#15 | -1573.5%#14 | -495.0%#13 | — | -98.3%#8 | — |
| SGHT | $446M#3 | — | 8.4x#10 | 5.8x#9 | -3.1%#13 | 25.4%#5 | -48.0%#9 | -72.6%#9 | -266.6%#12 | 5#3 | 130.3%#1 | — |
| CARL | $416M#4 | 138.5x#4 | 4.9x#8 | 8.2x#12 | 85.9%#2 | -22.2%#11 | -60.5%#12 | -35.2%#7 | -57.3%#10 | 5#3 | — | — |
| CLPT | $401M#5 | — | 37.2x#12 | 10.8x#14 | 17.8%#6 | -35.0%#14 | -65.4%#13 | -237.0%#12 | — | — | — | — |
| SI | $373M#6 | 0.1x#1 | 3.0x#4 | 7.9x#11 | 49.6%#4 | -158.4%#15 | -55.6%#10 | -32.5%#6 | -22.9%#6 | 3#10 | — | — |
| OFIX | $371M#8 | — | 0.9x#1 | 0.5x#2 | 2.9%#11 | 26.8%#4 | -9.9%#5 | -21.5%#4 | -14.9%#4 | 5#3 | -38.6%#6 | — |
| OBIO | $363M#9 | — | 3.6x#5 | 10.8x#15 | 1169.2%#1 | 13.6%#9 | -154.7%#14 | -52.8%#8 | -54.9%#9 | — | — | 5.5%#2 |
| MOBI | $360M#10 | — | 2.1x#3 | — | — | — | — | 0.0%#2 | — | — | — | — |
| TMCI | $299M#11 | — | 4.4x#7 | 1.4x#3 | 1.6%#12 | -5.8%#10 | -25.5%#7 | -87.1%#10 | -47.4%#8 | 2#11 | -35.0%#5 | — |
| TLSI | $293M#12 | — | 44.7x#14 | 6.5x#10 | 53.4%#3 | -30.6%#13 | -59.7%#11 | -598.9%#13 | — | 5#3 | 0.2%#4 | — |
| EMBC | $288M#13 | 3.5x#2 | — | 0.3x#1 | -3.8%#14 | 21.8%#7 | 22.4%#1 | — | 27.0%#1 | 6#2 | -62.1%#7 | 12.1%#1 |
| ANIK | $279M#14 | — | 2.0x#2 | 2.5x#6 | -5.9%#15 | 80.4%#2 | -9.8%#4 | -8.0%#3 | -8.8%#3 | 4#7 | — | — |
| INFU | $244M#15 | 30.6x#3 | 4.1x#6 | 1.7x#4 | 6.4%#9 | 182.6%#1 | 8.3%#2 | 11.2%#1 | 9.5%#2 | 9#1 | — | — |
Peer set: US filers sharing this company's SEC industry classification (SIC 3841). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Some peers are still being computed, so this table covers part of the group and ranks are within the rows shown; it fills in shortly. 이 표는 생성 중 시간이 초과되어 그룹의 일부만 포함합니다. 순위는 표시된 행 내에서만 유효하며 곧 채워집니다. Table built 2026-09-16.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice